Private equity investment firm Thoma Bravo will acquire diagnostic medical imaging software vendor AMICAS Inc. for $217 million, the companies announced on Dec. 28.
The $5.35 per share price is 21% higher than Boson-based AMICAS' stock price was when the deal was announced. AMICAS sells radiology and cardiovascular information systems, and radiology and cardiology picture archiving and communication systems.
AMICAS in 2009 paid $39 million to acquire Emageon Inc., which sold complementary systems. AMICAS during the first nine months of 2009 lost $6.1 million on revenue of $62 million. Under acquisition terms, AMICAS may solicit alternative proposals for 45 days starting Dec. 24.
Thoma Bravo, with offices in Chicago and San Francisco, currently has investments in 11 other software/technology companies serving multiple industries.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access